Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-32.28M
↓ 64% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-19.64M
Historical baseline
PeriodValueYoY Change
TTM$-32.28M-16.9%
2024$-27.60M+12.0%
2023$-31.35M-13.3%
2022$-27.68M-35.1%
2021$-20.50M-40.8%
2020$-14.56M+15.4%
2019$-17.21M-51.1%
2018$-11.39M-46.0%
2017$-7.80M-28.6%
2016$-6.07M-